SG Americas Securities’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-10,331
| Closed | -$118K | – | 3262 |
|
|
2017
Q3 | $118K | Buy |
10,331
+644
| +7% | +$7.36K | ﹤0.01% | 2680 |
|
|
2017
Q2 | $95K | Buy |
9,687
+6,322
| +188% | +$62K | ﹤0.01% | 2561 |
|
|
2017
Q1 | $82K | Sell |
3,365
-4,667
| -58% | -$114K | ﹤0.01% | 2684 |
|
|
2016
Q4 | $258K | Buy |
8,032
+5,498
| +217% | +$177K | ﹤0.01% | 1915 |
|
|
2016
Q3 | $127K | Buy |
+2,534
| New | +$127K | ﹤0.01% | 2550 |
|
|
2015
Q3 | – | Sell |
-1,303
| Closed | -$127K | – | 2491 |
|
|
2015
Q2 | $127K | Sell |
1,303
-863
| -40% | -$84.1K | ﹤0.01% | 1898 |
|
|
2015
Q1 | $202K | Buy |
2,166
+356
| +20% | +$33.2K | ﹤0.01% | 1628 |
|
|
2014
Q4 | $161K | Buy |
+1,810
| New | +$161K | ﹤0.01% | 2326 |
|
|
2014
Q2 | – | Sell |
-1,694
| Closed | -$67K | – | 2371 |
|
|
2014
Q1 | $67K | Buy |
+1,694
| New | +$67K | ﹤0.01% | 1978 |
|
|
2013
Q4 | – | Sell |
-2,330
| Closed | -$70K | – | 2737 |
|
|
2013
Q3 | $70K | Buy |
+2,330
| New | +$70K | ﹤0.01% | 2395 |
|